Fiche centre
NYU Langone Health
New York — United States
Essais liés31clinical trials
VilleNew Yorklocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06667908
Essais cliniques associés
31| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Transcutaneous electrical nerve stimulation unit (TENS) | Maladie rénale chronique | Non applicable | NCT05981183 | Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population | RECRUITING |
| Empagliflozin 10 MG | Maladie rénale chronique | Phase 2 | NCT05786443 | SEED — Safety and Efficacy of Empagliflozin in Hemodialysis | ACTIVE_NOT_RECRUITING |
| BrioVAD System | Insuffisance cardiaque | Non applicable | NCT06310031 | INNOVATE — Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure | ACTIVE_NOT_RECRUITING |
| Active taVNS | Maladie rénale chronique | Non applicable | NCT06927024 | Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD) | RECRUITING |
| Herpes Zoster Subunit (HZ/su) Vaccine | Lupus | Phase 4 | NCT05559671 | Safety of the Herpes Zoster Subunit Vaccine in Lupus | RECRUITING |
| Active tPBM-2.0 | Alzheimer | Phase 2 | NCT04784416 | Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD) | COMPLETED |
| Flow diversion | Accident vasculaire cérébral | Non applicable | NCT07143019 | PIANO — The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms | RECRUITING |
| AFSW Guided DOAC | Accident vasculaire cérébral | Phase 3 | NCT05836987 | REACT-AF — The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation | RECRUITING |
| Vicadrostat | Insuffisance cardiaque | Phase 3 | NCT06424288 | A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure | RECRUITING |
| POWERbreathe KH2 | Insuffisance cardiaque | Non applicable | NCT07862738 | Inspiratory Muscle Training in Hospitalized Patients With Heart Failure Awaiting Advanced Therapies | NOT_YET_RECRUITING |
| Retatrutide | Maladie rénale chronique | Phase 3 | NCT06383390 | The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) | ACTIVE_NOT_RECRUITING |
| Iza-bren | Cancer | Phase 2/3 | NCT07100080 | Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01) | RECRUITING |
| Histotripsie — HistoSonics Edison System | Cancer | Non applicable | NCT07853690 | Histotripsy in Biliary Tract Cancer | RECRUITING |
| JNJ-90301900 | Cancer | Phase 2 | NCT06667908 | CONVERGE — A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) | RECRUITING |
| Home Urine Testing | Lupus | Non applicable | NCT07823478 | HEALTH Home Urinalysis Testing | RECRUITING |
| Irreversible Electroporation | Cancer | Non applicable | NCT04972097 | PRESERVE — Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue | COMPLETED |
| Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma | Cancer | À vérifier | NCT03878550 | Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma | ACTIVE_NOT_RECRUITING |
| Donanemab | Alzheimer | Phase 3 | NCT04437511 | A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) | ACTIVE_NOT_RECRUITING |
| ETX101 | Épilepsie | Phase 1/2 | NCT05419492 | ENDEAVOR — A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome | RECRUITING |
| Tazbentetol | Sclérose latérale amyotrophique | À vérifier | NCT07088159 | Intermediate-size Patient Population Expanded Access Protocol | AVAILABLE |
| RE104 for Injection | Sclérose latérale amyotrophique | Phase 2 | NCT07002034 | RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses | RECRUITING |
| Hydroxychloroquine | Lupus | Phase 3 | NCT05799378 | SHIELD — Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease | RECRUITING |
| HEAL-SLE: Holistic Energy for Alleviating Lupus Symptoms | Lupus | Non applicable | NCT07203157 | HEAL-SLE: Holistic Energy for Alleviating Lupus Symptoms | ACTIVE_NOT_RECRUITING |
| Histotripsie — HistoSonics Edison System | Cancer | À vérifier | NCT06486454 | Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study) | RECRUITING |
| Histotripsie — HistoSonics Edison System | Cancer | Non applicable | NCT05820087 | The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) | ACTIVE_NOT_RECRUITING |
| zorevunersen | Épilepsie | Phase 3 | NCT06872125 | A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome | ACTIVE_NOT_RECRUITING |
| BHV-7000 | Épilepsie | Phase 2/3 | NCT06309966 | RISE 3 — Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy | ACTIVE_NOT_RECRUITING |
| YOPD — Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms | Parkinson | À vérifier | NCT07752355 | YOPD — Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms | RECRUITING |
| Remotely Supervised Transcranial Direct Current Stimulation (RS - tDCS) | SEP | Non applicable | NCT06816004 | VANISH-MS — Noninvasive Vagal Nerve Stimulation | ACTIVE_NOT_RECRUITING |
| Robotic-Assisted Surgery | Myasthénie | Non applicable | NCT05150210 | SP Thoracic IDE Study | ACTIVE_NOT_RECRUITING |
| ONC201 | Cancer | À vérifier | NCT05392374 | Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas | NO_LONGER_AVAILABLE |